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Background: CGGBP1 is a repetitive DNA-binding transcription regulator with target sites at CpG-rich sequences such
as CGG repeats and Alu-SINEs and L1-LINEs. The role of CGGBP1 as a possible mediator of CpG methylation however
remains unknown. At CpG-rich sequences cytosine methylation is a major mechanism of transcriptional repression.
Concordantly, gene-rich regions typically carry lower levels of CpG methylation than the repetitive elements. It is well
known that at interspersed repeats Alu-SINEs and L1-LINEs high levels of CpG methylation constitute a transcriptional
silencing and retrotransposon inactivating mechanism.
Results: Here, we have studied genome-wide CpG methylation with or without CGGBP1-depletion. By high throughput
sequencing of bisulfite-treated genomic DNA we have identified CGGBP1 to be a negative regulator of CpG methylation
at repetitive DNA sequences. In addition, we have studied CpG methylation alterations on Alu and L1 retrotransposons
in CGGBP1-depleted cells using a novel bisulfite-treatment and high throughput sequencing approach.
Conclusions: The results clearly show that CGGBP1 is a possible bidirectional regulator of CpG methylation at Alus,
and acts as a repressor of methylation at L1 retrotransposons.Background
CGGBP1 is a DNA-binding, transcription regulatory pro-
tein shown to have binding sites on CGG tandem repeats
as well as repetitive clusters of ribosomal RNA genes [1-3].
The CpG-richness of CGGBP1-binding sequences raises
the question whether CpG methylation may be a mechan-
ism underlying transcription-regulation by CGGBP1. Des-
pite evidence of transcriptional silencing by binding of
CGGBP1 to unmethylated CGG repeats [2,4], the effects of
CGGBP1 on CpG methylation have never been studied.
Recently CGGBP1-binding was demonstrated at repetitive
DNA including transcription-regulatory regions of Alu-
SINEs and L1-LINEs [5]. CGGBP1 acts as a growth-
specific transcription suppressor of a subset of Alu-SINEs
[5]. Unlike the gene-rich regions, the repetitive DNA e.g.
peri-centromeric, sub-telomeric and satellite repeats as well
as interspersed repeats, including Alu and LINE-1 elements
carry high methylation levels [6-8].* Correspondence: umashankar.singh@igp.uu.se
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unless otherwise stated.Methylation of cytosine bases on DNA is a pivotal epi-
genetic mark important for development and differenti-
ation [6,7,9-12] and importantly also required for
suppression of transcription of repetitive elements in the
genome [8]. Cytosine methylation has been most studied
in the CpG context, although it also occurs in CHG and
CHH contexts [13,14].
DNA methyltransferases either methylate cytosine
bases de novo (DNMT3A and DNMT3B) [15] or at
hemi-methylated sites during replication (DNMT1)
[6,16,17], although context-specific de novo methylation
by DNMT1 has been reported [12,18,19]. SUV39H,
HDACs, HMTs, pRB, p23, DMAP1, PCNA and MBD2
are some proteins that regulate activities of DNMTs
[6,7,17,20-24]. Of these, all except HDACs and pRB, are
positive effectors of their activities and cytosine methyla-
tion. Erasure of CpG cytosine methylation involves oxi-
dation and deamination of methylated cytosine by TET
and AICDA proteins respectively followed by base-
excision repair based on the complementary guanidine
[25-27]. An interplay between positive and negative ef-
fectors of CpG methylation makes sure that even within
the constitutive heterochromatin, cytosine methylationl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lated and methylated cytosine bases is maintained. The
factors restricting CpG methylation from invading all
cytosine bases remains largely unknown. Unraveling the
function of potential novel regulators of cytosine methy-
lation such as CGGBP1 thus becomes important.
Results
To elucidate the role of CGGBP1 in regulation of CpG
methylation we performed global as well as targeted (at
Alu and LINE-1 repeats) methylation analysis of genomic
DNA from normal human fibroblasts after an acute deple-
tion of CGGBP1.
1064Sk cells were transduced with control or CGGBP1-
targeting shmiR-lentiviruses and CGGBP1-depletion was
confirmed by western blotting (Additional file 1). Genomic
DNA was extracted and used for methylation analysis
by colorimetry using antibody directed against methyl-
cytosine (Epigentek). The results showed that cytosineFigure 1 Global methylation changes upon CGGBP1-depletion. A: Colorim
colorimetry signal from 3 independent assays (mean ± SEM). B: GeneSpring o
is significant between CGGBP1-depleted and Control samples. Y-axis shows C
Frequency plotting of CpG methylation changes across different ranges of me
methylation frequency bins and Y-axis shows C count (%).methylation was increased upon CGGBP1 depletion
(Figure 1A; Ratio paired T test p=0.0211).
Then, paired-end sequencing was performed for the
control and CGGBP1-depleted DNA after bisulfite treat-
ment. The reads were mapped (only unique alignments
reported) using Bismark [28] and the data further analyzed
using GeneSpring v12.6.1 (Agilent). For bisulfite treat-
ment, 100% unmethylated phage lambda DNA was used
as spike-in control and bisulfite conversion efficiency in
both samples was ascertained as 95% (full details in the
section on methods). Since bisulfite treatment converts
unmethylated cytosine bases to uracil (which eventually in
PCR gives rise to adenine), an increase in cytosine content
(C count; expressed as % of total bases sequenced) upon
bisulfite treatment becomes a measure of methylated cyto-
sine bases.
Supporting the colorimetry results, the bisulfite-
treatment-sequencing experiment also showed increased
cytosine content in CGGBP1-depleted cells in CpGetric analysis reveals an increase in CpG methylation. Y-axis shows
utput showing changes in CpG methylation. The increase in methylation
count (%, [calculated as C count x100/total number of nucleotides]). C:
thylation. This plot shows binning of data depicted in 1B. X-axis shows
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unmethylated CpG increased from 25.03 in control to
26.97 in CGGBP1 depleted sample (individual % methyl-
ated and % unmethylated C counts shown in Figure 1B).
This showed that acute CGGBP1-depletion increased
CpG methylation. The significance of increase in CpG
methylation has been calculated using Fisher’s exact test
(p < 0.01) inbuilt in GeneSpring.
A distribution of C% content with respect to Methyla-
tion% showed that this increase in CpG methylation
upon CGGBP1-depletion was maximal at highly methyl-
ated regions exhibiting 70%–90% methylation (Figure 1C).
This indicated that upon CGGBP1 depletion unmethy-
lated regions did not become aberrantly methylated, rather
already significantly methylated regions became slightly
but significantly hypermethylated.
To ensure that (i) the small yet significant increases in
methylation measured in terms of C count was not due to
any base composition bias between the control and
CGGBP1-depleted DNA samples, and (ii) that the changes
in C count were indeed due to bisulfite conversion, we next
performed Illumina paired-end sequencing without any bi-
sulfite treatment on the same samples as used for sequen-
cing after bisulfite conversion (mentioned above). The C
count was found to be unaffected by CGGBP1-depletion in
the absence of bisulfite conversion (Additional file 2 (A;
black line versus green line)) but was significantly (Chi
square test with Yate’s correction p < 0.0001) increased by
CGGBP1-depletion in presence of bisulfite conversion
(Additional file 2 (A; red line versus orange line)). Also, spe-
cifically in bisulfite-converted DNA, the relative changes in
C counts (and G counts on reverse strand) were associated
with inverse and significant changes in T counts (and A
counts on reverse strand) when CGGBP1-shmiR samples
were compared against Control shmiR with the latter
values normalized to 1 (Fisher’s exact test p < 0.0001;
Additional file 2 (B)). These results confirmed that the
C count increase observed upon bisulfite-treatment-
sequencing in CGGBP1-depleted sample was genuinely
due to increased cytosine methylation.
Region annotation of cytosine bases exhibiting in-
creased methylation showed that >99% of them were lo-
cated in inter-genic regions (more than 5Kb from
nearest known genes). The repetitive DNA sequences
are silenced by methylation and CGGBP1 is a repeat-
binding protein with affinity for unmethylated DNA. So
we asked if the increase in methylation upon CGGBP1-
depletion occurs at repetitive DNA. Non-overlapping
sequences of −100 to +100 bps regions flanking the
methylated cytosine bases were extracted and subjected
to repeat identification by RepeatMasker [29]. A sub-
stantial fraction of the differentially methylated regions
were located in repetitive regions of the genome as men-
tioned below: interspersed repeats (6.57%), small RNA(3.91%), simple repeats (21.69%) and satellite repeats
(20.56%) (Additional file 3). CGGBP1 depletion thus
seemed to increase cytosine methylation at repetitive
DNA in the inter-genic regions.
Alu and LINE-1 repeats constitute a major fraction of
interspersed repeats in our genome. They are silenced by
CpG methylation and thus also serve as major cytosine
methylation repositories. Also, Alu-SINEs and L1-LINEs
have been recently shown to be major CGGBP1-binding
sites [5]. To identify the changes in methylation occurring
at Alu and LINE-1 repeats upon CGGBP1-depletion, we
established PCR conditions to amplify Alu and LINE-1
repeats genome-wide from bisulfite-converted DNA
(Additional file 4; and see methods for details). By this
approach we could measure global changes in Alu and
LINE-1 methylation on all cytosine residues in a 220 bp
Alu amplicon and a 429 bp LINE-1 amplicon (bench-
mark lengths derived from distance between primers in
the consensus sequences) (Additional file 4). The Alu
and LINE-1 bisulfite PCR products were sequenced on
PacBio platform and analyzed to reveal any changes in
CpG methylation. The Alu PCR products showed some
concatenation in sequencing library preparation but
since the methylation change was being calculated as a
drift from C to T, this did not affect the results. The
mean ± S.D. lengths of the Control shmiR and CGGBP1
shmiR LINE-1 PCR products were heavily centered
around the expected full-length amplicon (Additional
file 5). Sequences for the entire length of amplicon for
all fragments were not achieved, so we included in our
analysis only sequences, which were at least 100 bases
long. Out of >7000 Alu sequences per sample and
>10000 LINE-1 sequences per sample, there were no
duplicates, showing that the PCR product indeed amp-
lified from different Alu and LINE-1 elements genome-
wide. The alignment of the individual sequences against
consensus Alu and LINE-1 sequences are shown in the
files submitted to NCBI GEO database (GSE60784).
The level of methylation of CpG dinucleotides in this
case was measured as the frequency of CpG. The mean
CpG methylation on Alus was significantly increased
(Figure 2A; CpG increased and TpG decreased; T test p
< 0.0001). Although there was an increase in Alu methy-
lation overall, an inspection of the distribution of methy-
lation frequencies indicated two different directions of
methylation change. A major fraction had increased
(>12%) methylation and a minor fraction had decreased
(<8%) methylation (Figure 2B) In the CGGBP1 shmiR
sample, the deviation of <8% and >12% fractions from
expected (distribution of <8% and >12% fractions in
Control shmiR sample) was highly significant (Chi
square test, p < 0.001). Plotting only the sequences hav-
ing CpG methylation <8% and >12% further highlighted
the possible bidirectional change in Alu methylation
Figure 2 Alu and LINE-1 repeats exhibit methylation changes upon CGGBP1-depletion. A: Mean methylation increase on Alu repeats measured by CG
frequency per PCR product sequence. Y-axis shows nucleotide frequency calculated per sequence. X-axis shows the samples and treatments.
B: Frequency distribution of Alu methylation across different ranges shows decrease (<8%) and increase (>12%) at extremes in CGGBP1 shmiR
sample as compared to Control shmiR sample. Y-axis shows relative frequencies of CG (a measure of methylation; normalized for different
number of sequences per sample). C: Plotting of the >12% and <8% methylation subset from B shows the tailing of differentially methylated
sequences at both extremes clearly. D: Frequency plot of data plotted in C and best curve fit shows sum-of-two-Gaussian fit for CGGBP1-depleted
sample and a single Gaussian distribution for control sample suggesting that indeed there are two groups of methylation levels for Alus in CGGBP1
shmiR but only one group of methylation level in Control shmiR sample. E and F: Increase in CpG content negatively correlated with TpG frequency in
both samples establishing the fact that the changes in cytosine content was indeed due to bisulfite conversion of unmethylated cytosines. G: Increase
in methylation on LINE-1 elements was significant with no bidirectional heterogeneity as seen for the Alus. H: Frequency plotting showed that <7.5%
(marked with dotted line) methylation was prevalent in control sample, but >7.5% methylation was prevalent in CGGBP1-depleted sample (values
normalized for different number of sequences per sample). I and J: CpG and TpG frequencies on LINE-1 exhibited inverse correlations in CGGBP1 and
control shmiR samples establishing the fact that the changes in cytosine content was indeed due to bisulfite conversion of unmethylated cytosines.
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and >12% subjected to best distribution fit identified a
sum-of-two-Gaussians clearly in CGGBP1-depleted sam-
ple but only a major single Gaussian distribution in Con-
trol sample (Figure 2D). That the changes in CpG
content indeed occurred due to bisulfite treatment was
confirmed because the changes in CpG content corre-
lated inversely with changes in TpG content as bisulfite
treatment causes a C- > T drift (Figures 2E and F) (for
both correlation plots, R2 > 0.18 with p < 0.0001).
CpG methylation on LINE-1 also showed a significant
increase after CGGBP1-depletion (Figure 2G; CpG in-
crease and TpG decrease, T test p < 0.001). The control
samples had higher content of <7.5% methylated LINE-1
elements, whereas the population of >7.5% methylated
LINE-1 repeats increased in CGGBP1-depleted sample
(Figure 2H) (distribution shift significant; Chi square test,
p < 0.001). By plotting the CpG content against TpG con-
tent on the LINE-1 repeats, again we found a strong in-
verse correlation, confirming that the increase in CpG
content indeed occurs due to methylation (Figures 2I
and J) (R2 > 0.4 and p < 0.0001). Since a fraction of the
TpG content is a part of the native sequence of Alu
and LINE-1 elements which does not arise out of C- >
T conversion, the observed inverse correlation between
the CpG and TpG may actually underrepresent the true
inverse correlation between methylated CpG versus bi-
sulfite conversion-derived TpG.
Discussion
To unravel the possibility that CGGBP1 with target sites at
CpG-rich sequences may also function as a possible medi-
ator of CpG methylation we performed global and targeted
methylation analysis of genomic DNA from normal human
fibroblasts after an acute depletion of CGGBP1. The results
from these experiments now clearly show that CGGBP1 is
a net negative regulator of CpG methylation. The regions
most affected by CGGBP1-dependent methylation regula-
tion are inter-genic regions including simple repeats, satel-
lite DNA and interspersed repeats. An in-depth nucleotide
level analysis of the methylation changes at discrete CpG
nucleotides will generate more information about the
DNA sequence context in which CGGBP1 targets methyla-
tion at CpG sites. Although CGG repeats constitute a
major binding site for CGGBP1, there are CGG-free re-
gions to which it binds. These include CDKN1A promoter
[30], telomeric repeats [31], a CGG repeat-free SNP rs115
97367*G [32] and Alu and LINE promoters in addition to
other repetitive elements in the genome [5]. Thus the effect
of CGGBP1 depletion on methylation at CGG repeat-free
regions is not surprising.
Targeted analysis of methylation on Alu and LINE-1 re-
peats genome-wide upon CGGBP1-depletion and demon-
strated an increase in CpG methylation. These regions areusually constitutively inactivated by, and carry a major
fraction of, CpG methylation. Obviously these regions are
under constant influence of mechanisms that ensure high
levels of methylation. This would include constant surveil-
lance by DNA methyltransferases as well as constitutive
heterochromatin-associated histone modifiers. Since cyto-
sine methylation erasure mechanisms, including oxidation,
deamination and subsequent base excision processes,
would counteract methylation at these repetitive regions,
they may not be 100% methylated at any particular time
point. The mechanism underlying methylation increase
upon CGGBP1-depletion may either involve an increase
of de novo methylation, or a decrease of methylation eras-
ure, or both combined. Given the already high methylation
levels at repetitive regions, a further augmentation of de
novo methyltransferases activity at these elements is diffi-
cult to comprehend. Therefore the possibility that
CGGBP1 depletion mitigates methylation erasure appears
more likely. An analysis of the recently published gene ex-
pression profile of CGGBP1-depleted cells supports our
current findings. From this dataset, an identification of
expression profiles of genes with known functions in cyto-
sine methylation regulation showed that CGGBP1-
depletion decreases the expression of genes involved in
cytosine/methyl-cytosine oxidation (the APOBEC family
of enzymes) and increases the expression of positive effec-
tors of CpG methylation including DNMT1 (Additional
file 6). Alternatively, since CGGBP1 has affinity for
unmethylated repetitive DNA [4] it is possible that
CGGBP1 shields sub-regions of repetitive DNA from de
novo methyltransferases activity. Down regulation of
CGGBP1 will then expose these regions to methylation-
incorporating machinery. This would result in methylation
increase, as observed in the present investigation.
Interestingly, even if CGGBP1 depletion increases
cytosine methylation, it does so not at unmethylated re-
gions or regions with very low cytosine methylation (for
example CpG islands associated with gene-rich regions),
rather at already significantly methylated repetitive DNA
regions. A decrease in methylation at repetitive DNA or
an increase in methylation at CpG islands could be high
in magnitude, but a further increase in methylation at
already highly methylated regions can only be limited.
This may explain the only low but highly significant
changes in methylation levels observed upon CGGBP1
depletion.
The possibility of bidirectional change in Alu CpG
methylation suggests that different Alu elements may be
subjected to different mechanisms of CpG methylation
regulation by CGGBP1. Further work is needed to iden-
tify which kinds of Alu elements exhibit decreased
methylation upon CGGBP1-depletion. A classification of
Alu sequences obtained in the current work into differ-
ent sub-families is not possible due to two factors: (i)
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annealing and cross-amplification of highly similar Alu
sequences belonging to different subfamilies, and (ii)
site-specific C- > T variations could not be identified as
differences in original genomic DNA or as occurring due
to bisulfite conversion. Although the primers were
intended to be selected from as highly conserved regions
of Alus as possible, it is important to note that due to
sequence variations between different Alu elements, there
could be a minor PCR amplification bias against the Alu
elements which do not match completely with the primer
sequences or have unmethylated CpG dinucleotides in the
priming region.
The approach employed in this study to study genome-
wide methylation changes upon CGGBP1 depletion mea-
sures the overall changes in cytosine methylation without
giving a microscopic base-level information about the
methylation targets of CGGBP1. These data give a sound
platform to build upon to uncover the sequence contexts
in which CGGBP1 exerts methylation regulation at spe-
cific sites.
Though several positive effectors of DNA methylation
are known, to the best of our knowledge, apart from
histone-modifying proteins HDACs and HMTs and pRB,
this is the first factor described to have negative effects on
cytosine methylation. We therefore have discovered a
unique feature of CGGBP1 that is important for regulation
of DNA methylation. This has implications on silencing of
Alu and LINE-1 repeats, heterochromatin formation on
simple and satellite repeats and hence on genome integrity
and function.
Conclusions
CGGBP1 depletion results in increased CpG methylation
at repetitive DNA sequences. These include Alu-SINEs
and L1-LINEs. A subset of Alu-SINEs however display
decreased methylation suggesting a bi-directionality in
the effects of CGGBP1 on CpG methylation on Alu-
SINEs. Gene expression data suggest that a transcrip-
tional deregulation of CpG methylation-regulatory genes
could underlie this effect of CGGBP1.
Methods
CpG methylation measurement by colorimetry
CpG methylation in CGGBP1 shmiR or Control shmiR-
transduced cells was measured by using MethylFlash
Methylated DNA Quantification Kit (Colorimetric) from
EpiGentek. Signals were extracted using colorimeter
(Cole Parmer). Raw signals from 3 colorimetric analyses
were plotted.
Cell culture and shmiR transduction
1064Sk normal human foreskin fibroblasts (passage 12)
were cultured in MEM (SIGMA), 10% FCS (SIGMA) and0.05% Glutamine (SIGMA). Passaging was done using
Trypsin (SIGMA). Lentiviral shmiR against CGGBP1
(cocktail of three target sequences) or control (non-target-
ing) were obtained from ThermoScientific. Transductions
were done at an MoI of 6 using Polybrene. After 24 h and
72 h of transduction, medium was changed. At 96 h post-
transduction, cells were harvested and CGGBP1 knock-
down confirmed by western blot (Additional file 1) as
described before. Genomic DNA was extracted from same
samples using Qiagen Genomic DNA extraction kit.
Bisulfite conversion of DNA and lIlumina library
preparation
Bisulfite conversion of DNA was performed using EZ
methylation Kit (Zymo Research). Library prep was car-
ried out using the NEXTflex Bisulfite (cat# 5119–01) Se-
quencing kit provided by Bioo Scientific, according to
the provided protocol. Volumes were calculated for the
two samples that gave 1ug input into the fragmentation
and combined with nuclease free water to 130ul in a
Covaris tube and fragmented using our established
protocol (we used the Covaris S2 acoustic sonicator
paired with Covaris MicroTube AFA Fibre pre-split
(520045) tubes with the following settings: Duration:
50 sec, Duty Cycle: 20%, Intensity: 5.0, Cycles/Burst:
200). Fragmented DNA was then speed-vac concentrated
to 39ul working volume for the library prep reaction and
combined with 1ul of 500 pg/ul Lambda DNA spike.
Illumina sequencing and data analysis
Samples were run on Illumina Sequencers by standard
methods. In addition to the library made from bisulfite-
treated DNA, libraries prepared from untreated DNA sam-
ples were also sequenced. Paired-end reads were aligned
using Bowtie 2 [33] for non-bisulfite-treated samples or
Bowtie 2 in Bismark for bisulfite-treated samples. The
sequences were aligned against a joint human + lambda
reference.
The under-conversion rate was derived by subsetting the
lambda read alignments and dividing the number of C-C
matches with the total coverage of C positions in the
lambda genome (lambda DNA was 100% unmethylated, so
all remaining Cs were ascribed as occurring due to under-
conversion). In both samples the Lambda DNA spike in
controls indicated 95% conversion efficiency. The nucleo-
tide content of non-bisulfite-treated samples was calculated
using Compseq [34]. For bisulfite-treated samples, the Bis-
mark output (BAM files) was used as input in GeneSpring
(Agilent) and subjected to derivation differentially methyl-
ated cytosine residues and their annotation with respect to
presence in or vicinity of known genes. The parameters
used in GeneSpring were as follows: Methylation identifi-
cation using Fisher’s test p = 0.01, bisulfite conversion error
rate=0.05 (5%) using external standard (lambda DNA in
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cytosine residues were pulled from Hg19 assembly using
tools embedded in Galaxy Project [35]. The repeat content
of the sequences were analyzed using RepeatMasker [29].
Alu and LINE-1 amplification, PacBio sequencing and data
analysis
Alu and LINE-1 repeats were amplified genome-wide
from bisulfite-converted DNA samples using the following
primers: GAGGTCGAGGCGGGAGGATCG and CGTT
TAGGTTGGAGTGTAGTGGCGCG for Alu repeats
(amplicon size 220 bps from Alu consensus sequence),
and ATTTTTGTATTTTTATTTGAGGTAT and AACT
ATAATAAACTCCACCCAATTC for LINE-1 repeats
(amplicon size 429 bps from LINE-1 consensus sequence).























PCR cycling conditions were: 35 cycles of 94°C 30 sec,
54°C 40 sec and 72°C 1 min for LINE-1 and 94°C 5 min,
20 cycles of 94°C 30 sec, 50°C 25 sec and 72°C 45 sec
for Alus. Several reactions for Alus were pooled in
because of low yield. Increasing the number of cycles
gave concatenated products due to an imperfect dupli-
cated repeat-nature of Alu amplicon. The approximately
90 bps product seen in Alu PCR product is due to genu-
ine annealing of the forward primer in Alu right arm.
The 220 bps Alu product is derived from forward primer
annealing in left arm. A quality control gel picture of
Alu and LINE-1 PCR products is shown in Additional
file 2. The indicated 220 and 429 bps bands were excised
out using Qiagen gel elution kit and subjected to PacBio
Library preparation and sequencing. SMRT bell libraries
were produced using Pacific Biosciences 1.0 templateprep kit according to the manufacturer’s instructions. Li-
braries were constructed following Pacific Biosciences
500 bp template preparation and sequencing protocol.
Following SMRT bell construction, v2 primers were li-
gated and P5 polymerase was bound to the SMRT bell
library. Using C3 chemistry, the polymerase-template
complexes were sequenced on the Pacific Biosciences RS
II real-time sequencer. Each amplicon SMRT bell library
was sequenced on one SMRT cell using a 180 min movie
time. Using Pacific biosciences SMRT analysis software 2.2,
sequencing reads were filtered by quality and length and
single-molecule consensus reads generated from the insert
template. Reads obtained were matched against target con-
sensus sequences using Supermatcher (EMBOSS) [36].Statistics
Colorimetry data were analysed by performing T test in
MS Excel.
Chi square/Fisher’s Exact tests for significance of CpG
content variation was performed sing statistical options
embedded in GeneSpring (Agilent).
T tests for PacBio sequencing data, correlation coeffi-
cients and p values of CG to TG content changes were cal-
culated using GraphPad Prism. Nucleotide content changes
in non-bisulfite treated Illumina sequencing data were done
using MS Excel and GraphPad Prism. All graphs were gen-
erated using GraphPad Prism.Additional files
Additional file 1: Western blot analysis of CGGBP1 depletion: The
CGGBP1 band corresponds to 20 KDa and shows a clear decrease in
CGGBP1 shmiR sample as compared to Control shmiR sample. ACTB
(beta-actin) was used as a loading control.
Additional file 2: Comparison with unconverted DNA showed
specificity of effect of bisulfite-conversion on C% content changes. A:
Sequencing of non-bisulfite-treated samples showed no significant changes
in C content. Y-axis shows nucleotide count (%), which was split into C or
non-C fractions as plotted on X-axis. The corresponding C or non-C values
from CGGBP1 shmiR or Control shmiR samples were subjected to Chi-square
test. B: A plot of relative change (CGGBP1 shmiR/Control shmiR) in individual
nucleotide frequencies in bisulfite-converted or non-converted DNA samples;
Y axis shows the nucleotide frequency in CGGBP1-shmiR divided by Control
shmiR, thus normalising all control shmiR values to 1. The treatment of
bisulfite and the nucleotides are specified in legend and X-axis respectively.
The change in relative frequencies of C and G versus T and A respectively
across bisulfite treatment groups is significant as determined using a
Chi-square test (indicated by asterisks).
Additional file 3: Pie chart showing repeat-content identification
in the 100 bps flanking regions of differentially methylated
cytosines between CGGBP1-shmiR and Control shmiR samples.
More than 99% of the differentially methylated cytosines were located
>5Kb away from the nearest genes.
Additional file 4: Quality control gel picture of Alu and LINE-1 PCR
from bisulfite-converted genomic DNA: The Alu primers amplify a
220 bps product and LINE-1 primers amplify a 429 bps product
(size calculated based on consensus sequences, though the
amplicon is expected to be a mix of different fragments with minor
differences in molecular weight). The non-converted DNA did not give
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eluted from the gel and subjected to sequencing.
Additional file 5: Size distribution of sequence reads for LINE-1 PCR
products from bisulfite-treated DNA: A: Distribution of read lengths
in bins of 10 bases each from 100 bases onwards shows that the
maximum number of reads are of the size range between 400 and
500 bps. B: The raw lengths of all the reads included in the analysis for
the two samples have been shown. The remarkable accumulation of
reads in the expected sub-500 bps region is clearly visible. The mean
sequence sizes for Control shmiR and CGGBP1 shmiR LINE-1 PCR
products are 394.3 ± 75.27 and 401.0 ± 69.01 bps respectively.
Additional file 6: Analysis of effects of CGGBP1-depletion on
expression of CpG methylation-affecting genes from a previous
study (Agarwal et al., Cell Cycle, 2014). A: A heat map of selected set
of genes known to be involved in cytosine methylation regulation. The
Control- and CGGBP1-shmiR datasets are each represented by three
replicates. B: A quantification of the expression values shown in heat
map (A) presented as mean + SEM. T test has been employed to mark out
the significantly varying genes (asterisk marked). *=p < 0.01, **=p < 0.001,
***=p < 0.0001.
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